Amlodipine Besylate And Olmesartran Medoxomil Tablet, Film Coated
Product Images NDC 46708-215

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartran Medoxomil (NDC 46708-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Amloolmi 1020mg)

Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg film-coated tablet packaging label by Alembic Pharmaceuticals Limited. The label states the active ingredients quantities per tablet, dosage instructions directing to see the package insert, storage conditions, and batch and expiry date fields. The package contains 30 tablets and is marked Rx only.*

FDA Label Image

30's Bottle Pack (Amloolmi 1040mg)

Label for Amlodipine and Olmesartan Medoxomil Tablets, film coated, with a strength of 10 mg/40 mg. Contains 30 tablets per package. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. Includes storage instructions and a barcode. The label notes the tablets are prescription only and provides the NDC 46708-215-30.*

FDA Label Image

30's Bottle Pack (Amloolmi 520mg)

Label for Amlodipine and Olmesartan Medoxomil Tablets 5 mg/20 mg by Alembic Pharmaceuticals Limited. The film-coated oral tablets come in a package of 30 tablets. The label includes dosage strength, storage instructions, manufacturer details, barcode, and prescription-only designation.*

FDA Label Image

30's Bottle Pack (Amloolmi 540mg)

Label for Amlodipine and Olmesartan Medoxomil Tablets, film-coated oral tablets containing 5 mg amlodipine and 40 mg olmesartan per tablet. The package contains 30 tablets and is labeled for prescription use only. Manufactured by Alembic Pharmaceuticals Limited, India. Includes storage instructions and batch/expiry fields.*

FDA Label Image

Amlodipine Besylate (Amloolmi Amlo)

Chemical structure of Amlodipine besylate, showing its molecular arrangement including a benzene sulfonate group, as part of the active pharmaceutical ingredient in the product Amlodipine besylate and Olmesartran medoxomil.*

FDA Label Image

Figure 1 (Amloolmi Fig1)

This image contains four line graphs depicting the probability of achieving specific systolic and diastolic blood pressure targets at Week 8 with LOCF. Each graph compares placebo, Amlodipine 10 mg, and Amlodipine besylate and Olmesartran medoxomil (OM 40 mg) tablets. The targets are SBP <140 mmHg, DBP <90 mmHg, SBP <130 mmHg, and DBP <80 mmHg, plotted against baseline systolic or diastolic blood pressure.*

FDA Label Image

Olmesartan Medoxomil (Amloolmi Olmi)

Chemical structure diagram of the active ingredient Amlodipine besylate and Olmesartran medoxomil, showing the molecular bonds and arrangement of atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.